0.13Open0.13Pre Close0 Volume199 Open Interest17.50Strike Price0.00Turnover255.19%IV70.67%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.0896Delta0.0452Gamma79.46Leverage Ratio-0.0408Theta0.0001Rho7.12Eff Leverage0.0023Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet